TY - JOUR
T1 - Subgrouping of primary angle-closure suspects based on anterior segment optical coherence tomography parameters
AU - Nongpiur, Monisha E.
AU - Gong, Tianxia
AU - Lee, Hwee Kuan
AU - Perera, Shamira A.
AU - Cheng, Li
AU - Foo, Li Lian
AU - He, Mingguang
AU - Friedman, David S.
AU - Aung, Tin
N1 - Funding Information:
Funding: Grants from the Biomedical Research Council , Singapore and the National Medical Research Council , Singapore.
PY - 2013/12
Y1 - 2013/12
N2 - Purpose To identify subgroups of primary angle-closure suspects (PACS) based on anterior segment optical coherence tomography (AS-OCT) and biometric parameters. Design Cross-sectional study. Participants We evaluated 243 PACS subjects in the primary group and 165 subjects in the validation group. Methods Participants underwent gonioscopy and AS-OCT (Carl Zeiss Meditec, Dublin, CA). Customized software (Zhongshan Angle Assessment Program, Guangzhou, China) was used to measure AS-OCT parameters. An agglomerative hierarchical clustering method was first used to determine the optimum number of parameters to be included in the determination of subgroups. The best number of subgroups was then determined using Akaike Information Criterion (AIC) and Gaussian Mixture Model (GMM) methods. Main Outcome Measures Subgroups of PACS. Results The mean age of the subjects was 64.8 years, and 65.02% were female. After hierarchical clustering, 1 or 2 parameters from each cluster were chosen to ensure representativeness of the parameters and yet keep a minimum of redundancy. The parameters included were iris area, anterior chamber depth (ACD), anterior chamber width (ACW), and lens vault (LV). With the use of GMM, the optimal number of subgroups as given by AIC was 3. Subgroup 1 was characterized by a large iris area, subgroup 2 was characterized by a large LV and a shallow ACD, and subgroup 3 was characterized by elements of both subgroups 1 and 2. The results were replicated in a second independent group of 165 PACS subjects. Conclusions Clustering analysis identified 3 distinct subgroups of PACS subjects based on AS-OCT and biometric parameters. These findings may be relevant for understanding angle-closure pathogenesis and management. Financial Disclosure(s) The author(s) have no proprietary or commercial interest in any materials discussed in this article.
AB - Purpose To identify subgroups of primary angle-closure suspects (PACS) based on anterior segment optical coherence tomography (AS-OCT) and biometric parameters. Design Cross-sectional study. Participants We evaluated 243 PACS subjects in the primary group and 165 subjects in the validation group. Methods Participants underwent gonioscopy and AS-OCT (Carl Zeiss Meditec, Dublin, CA). Customized software (Zhongshan Angle Assessment Program, Guangzhou, China) was used to measure AS-OCT parameters. An agglomerative hierarchical clustering method was first used to determine the optimum number of parameters to be included in the determination of subgroups. The best number of subgroups was then determined using Akaike Information Criterion (AIC) and Gaussian Mixture Model (GMM) methods. Main Outcome Measures Subgroups of PACS. Results The mean age of the subjects was 64.8 years, and 65.02% were female. After hierarchical clustering, 1 or 2 parameters from each cluster were chosen to ensure representativeness of the parameters and yet keep a minimum of redundancy. The parameters included were iris area, anterior chamber depth (ACD), anterior chamber width (ACW), and lens vault (LV). With the use of GMM, the optimal number of subgroups as given by AIC was 3. Subgroup 1 was characterized by a large iris area, subgroup 2 was characterized by a large LV and a shallow ACD, and subgroup 3 was characterized by elements of both subgroups 1 and 2. The results were replicated in a second independent group of 165 PACS subjects. Conclusions Clustering analysis identified 3 distinct subgroups of PACS subjects based on AS-OCT and biometric parameters. These findings may be relevant for understanding angle-closure pathogenesis and management. Financial Disclosure(s) The author(s) have no proprietary or commercial interest in any materials discussed in this article.
UR - http://www.scopus.com/inward/record.url?scp=84888014400&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84888014400&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2013.05.028
DO - 10.1016/j.ophtha.2013.05.028
M3 - Article
C2 - 23916486
AN - SCOPUS:84888014400
SN - 0161-6420
VL - 120
SP - 2525
EP - 2531
JO - Ophthalmology
JF - Ophthalmology
IS - 12
ER -